Biotech · Private company
Glenmark Pharmaceuticals S.A.
Track this companyFree. Adds Glenmark Pharmaceuticals S.A. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials5
- Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast CancerPHASE1_PHASE2 · TERMINATED · started Apr 8, 2020ClinicalTrials.gov NCT03983395 · fetched Nov 12, 2026
- Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic DermatitisPHASE2 · COMPLETED · started May 31, 2018ClinicalTrials.gov NCT03568162 · fetched Nov 12, 2026
- Study of ISB 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple MyelomaPHASE1 · COMPLETED · started Oct 25, 2017ClinicalTrials.gov NCT03309111 · fetched Nov 12, 2026
- Phase 1 Study of Single Agent GBR 1302 in Subjects With HER2 Positive CancersPHASE1 · TERMINATED · started May 1, 2016ClinicalTrials.gov NCT02829372 · fetched Nov 12, 2026
- To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic DermatitisPHASE2 · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT02683928 · fetched Nov 12, 2026